Announcements Trials
Browse Landscape

Status

Recruiting 4Active not recruiting 3Terminated 1Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

pembrolizumab 70Cyclophosphamide 46Cisplatin 42Nivolumab 33Radiotherapy 30Paclitaxel 30Gemcitabine 30Carboplatin 28Docetaxel 26Dexamethasone 22atezolizumab 20Blood Specimen Collection 20Bevacizumab 19Rituximab 18Radiosurgery 18Fluorouracil 18fludarabine 17Magnetic Resonance Spectroscopy 17Leucovorin 17Lenalidomide 17Surveys and Questionnaires 16Oxaliplatin 16Doxorubicin 15Irinotecan 14Etoposide 14palbociclib 13Vincristine 13Radiotherapy, Intensity-Modulated 13Prednisone 13Letrozole 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Colonoscopy × 90 days × Clear all
NCT07502469 2026-03-31

BENEFIT

Elsan

Completed
341 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡